Skip to content
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us

Archive for October 2020

Biocartis announces market release of SeptiCyte RAPID test on Idylla

By Josephine Galatioto | October 6, 2020

Biocartis Group has released of SeptiCyte RAPID on Idylla as a CE-marked IVD test. SeptiCyte RAPID is a host-response test that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about one hour.

Read More

Q&A: Sepsis detection technology that can triage COVID-19 patients

By Josephine Galatioto | October 2, 2020

Ian Bolland caught up with Dr. Rolland Carlson, CEO of Immunexpress, to talk about a molecular diagnostic, SeptiCyte RAPID, which is used to detect sepsis and offers the potential to triage severe COVID-19 patients in the emergency department. Expand Briefly, tell us more about Immunexpress – how did the idea to start the company come…

Read More

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom


Contact Us


Privacy policy


 

Tweets by @Immunexpress

© 2023 Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 470, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com

Scroll To Top
We use cookies to ensure that we give you the best experience on our website. Continuing to use this website means you're ok with this. For more information about how we use cookies see our privacy policy.OkPrivacy policy